RiskNomics’ Russ Nassof was recently quoted in an article by Brett Walton with Circle of Blue, where water speaks. Here are a few excerpts: Health department officials investigate outbreaks, which are two or more cases linked to the same source. Those inquiries can be a boon to people filing a lawsuit if the health department […]
Eloquest Healthcare is proud to feature Russell Nassof, JD. Mr. Nassof discusses what inspires him most in his role as an Association for Vascular Access (AVA) Board Member, as well as important issues that are currently underappreciated. He also discusses the legal implications of vascular access associated blood stream infections.
Every day sick patients are treated in hospitals with broad spectrum antibiotics while their physicians wait days for culture results to identify infectious pathogen susceptibility to confirm or revise the treatment protocol. Unfortunately, many of these patients (especially those with sepsis) do not survive long enough to receive the precise life-saving drug and/or dosage needed. […]
Watch Russ Nassof discuss Reducing Risk and Liability for Vascular Clinicians Under the ACA and Other Regulations, as presented at various healthcare conferences around the USA.
I travel every week. It is one of those negatives that comes along with living in a beautiful state like Arizona where sometimes it seems as if the only business that goes on is centered around golf, hiking, or getting a nice tan.
Everyone who has ever stepped foot into a healthcare facility as either a patient or a visitor has undoubtedly witnessed the numerous patients attached to long lines of plastic tubing usually extending from the arm and connected to some type of plastic bag dispensing medication or some other vital necessity. In most cases, these devices […]
Prevention of adverse events in healthcare has rightfully become a cornerstone of progressive risk management and has been assuming greater importance every year. It is interesting that this focus on preventing adverse events in healthcare is relatively new and is now being increasingly linked with reimbursements and liability.